Literature DB >> 15247613

Vagal nerve stimulator pocket infections.

Niraj C Patel1, Morven S Edwards.   

Abstract

Vagal nerve stimulator pocket infections are uncommon but can cause considerable morbidity. We describe 3 children from our institution and 8 others previously reported with infection after vagal nerve stimulator implantation for seizure control. Infection was suppressed but recurred despite appropriate antimicrobial therapy when the device remained in situ. Device removal was required in all patients to achieve cure.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15247613     DOI： 10.1097/01.inf.0000131632.25375.c7

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  5 in total

1.  Vagal nerve stimulation for pharmacoresistant epilepsy in children.

Authors:  Jason S Hauptman; Gary W Mathern
Journal:  Surg Neurol Int       Date:  2012-10-31

2.  Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran.

Authors:  Hossein Pakdaman; Ali Amini Harandi; Mehdi Abbasi; Mohammad Karimi; Mohammad Ali Arami; Seyed Ali Mosavi; Karim Haddadian; Omidvar Rezaei; Sohrab Sadeghi; Guive Sharifi; Koroush Gharagozli; Parviz Bahrami; Farzad Ashrafi; Hosein Delavar Kasmae; Amirhossein Ghassemi; Mehran Arabahmadi; Behdad Behnam
Journal:  Neurol Sci       Date:  2016-07-11       Impact factor: 3.307

3.  Perioperative antibiotic use in vagus nerve stimulator implantation: a clinical series.

Authors:  Jeffrey S Raskin; Daniel Hansen; Arvind Mohan; I-Wen Pan; Daniel J Curry; Sandi Lam
Journal:  Childs Nerv Syst       Date:  2017-03-20       Impact factor: 1.475

4.  Revision of vagal nerve stimulation (VNS) electrodes: review and report on use of ultra-sharp monopolar tip.

Authors:  Wai Hoe Ng; Elizabeth Donner; Cristina Go; Amal Abou-Hamden; James T Rutka
Journal:  Childs Nerv Syst       Date:  2010-03-12       Impact factor: 1.475

5.  Vagus nerve stimulation to augment recovery from severe traumatic brain injury impeding consciousness: a prospective pilot clinical trial.

Authors:  Chen Shi; Steven R Flanagan; Uzma Samadani
Journal:  Neurol Res       Date:  2013-04       Impact factor: 2.448
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.